|Day Low/High||9.39 / 9.90|
|52 Wk Low/High||6.37 / 19.65|
Lululemon has been improving its practices and it is paying off in terms of performance despite what the company's founder Chip Wilson has been publicly saying, says Jim Cramer.
Wall Street made its best effort to extend a three-day winning streak into a fourth session but last-minute moves toward the flatline weren't enough on Thursday.
Maybe the yoga-apparel maker isn't such a downward dog after all.
Shoe giant should reveal details of pro athletes' endorsement deals.
Nike and Under Armour will be battling it out tonight when the Warriors play the Cavs in Game 3 of the NBA Finals.
U.S. stocks were little changed as the Beige Book muddied the outlook for interest rates and a few downgrades weighed on Nike shares.
Under Armour's impairment charge won't keep it from reaching its revenue goals.
As competition gets tougher, the sports apparel giant gets 2 downgrades.
There is no need to own Under Armour or Nike shares right now because both companies are dealing with the fall-out from the bankruptcy of Sports Authority.
It's a good idea to look beyond the big-caps, too.
Under Armour shares fall after-hours as the company forecasts a $23 million impairment charge related to The Sports Authority.
Weekend releases from Air Jordan and Under Armour could help turn around Foot Locker's forturnes, according to analysts.
The sneaker giant is like Apollo Creed in "Rocky" -- a cocky champ that may be underestimating the competition.
Shares shine after sporting deals and Wells Fargo want your wallet to be mobile.
Jim "El Capitan" Cramer writes cogently this morning about the short-term battlefield that he sees at Foot Locker (FL), Nike (NKE) and Under Armour (UA). Last week, I suggested that the "Peak Sneakers" battle would be a lengthy one, so I shorted Foo...
There are too many variables and too many shareholders itching to run.
The fall of Sports Authority may seem like a windfall for Dick's, but the company warns of short-term headwinds.
Nike will successfully defend its market-share title for at least the next 12 months.
Better-than-expected April sales supports our key investment themes, and our inclusion of these two names in the portfolio.
The two athletic apparel companies' upsides are minimal based on their current valuations, according to a Wells Fargo analyst.
Under Armour shares were rallying midday from their Wednesday dip.
The health and wellness theme is a good one and Jim Cramer wants people to start talking about it again.
Under Armour is going through disconcerting management changes, but the company is still a long term winner, says Jim Cramer.
Pfizer (PFE) has reportedly approached San Francisco based cancer drug maker Medivation (MDVN) about a buyout.
With prices now below $43 a test of $40 is coming along and further declines to $35 are possible.
Sports Authority has decided to sell its remaining assets rather than file for bankruptcy reorganization.
The market may be rising, but so-so economic data and earnings reports point to a growing divergence between value and price.
I started the day and ended the day at my highest net short exposure in over one-and-a-half years. I had my head in two research projects today rather than in the markets. It's just as well, given the action. Remember bulls/buyers live higher and be...